FDA orphan drug designation: treatment of acute graft-versus-host disease (aGVHD)
All entries for: ST Phi Therapeutics Co. Ltd.
September 12, 2025
ST Phi Therapeutics Co. Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of acute graft-versus-host disease (aGVHD)
